Largest biotech by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

CG Oncology has the lowest figure of the 11 biotech ranked by total debt, at SAR 11.3M, followed by Scholar Rock Holding (SAR 374M) and Adaptive Biotechnologies (SAR 492.2M). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
Lowest
CG OncologySAR 11.3M
Median
SAR 2.2B
Combined market value
SAR 3.15T
Countries
5
Not ranked
13no total debt on file

Market values as of .

Largest biotech by total debt
#CompanyTotal debt ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health CareSAR 11.3MSAR 26.8BSAR 299.82 1.25% up 85% up United States
2Scholar Rock HoldingSRRK · Health CareSAR 374MSAR 21.6BSAR 176.67 4.48% up 14% up United States
3Adaptive BiotechnologiesADPT · Health CareSAR 492.2MSAR 17.2BSAR 106.00 0.81% down 88% up United States
4Bio-TechneTECH · Health CareSAR 750.2MSAR 42.9BSAR 272.81 0.14% up 26% up United States
5RepligenRGEN · Health CareSAR 2BSAR 41.1BSAR 642.43 5.60% up 5% up United States
6ModernaMRNA · Health CareSAR 2.2BSAR 305.9BSAR 755.96 2.55% down 755% up United States
7QiagenQGEN · Health CareSAR 6.2BSAR 38.4BSAR 185.84 0.41% down 12% up Netherlands
8Halozyme TherapeuticsHALO · Health CareSAR 8BSAR 41.5BSAR 364.24 1.18% up 37% up United States
9BiogenBIIB · Health CareSAR 23.6BSAR 138.6BSAR 937.49 0.34% down 49% up United States
10Gilead SciencesGILD · Health CareSAR 93.5BSAR 788.3BSAR 635.59 0.48% down 33% up United States
11AmgenAMGN · Health CareSAR 204.8BSAR 906.8BSAR 1,676.43 2.40% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech have the lowest total debt?

CG Oncology (SAR 11.3M), Scholar Rock Holding (SAR 374M) and Adaptive Biotechnologies (SAR 492.2M) have the lowest total debt of the 11 biotech ranked here as of 18 Nov 2026, 16:31 UTC.

How many biotech are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 11 biotech ranked by total debt have a combined market value of SAR 3.15T as of 18 Nov 2026, 16:31 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.